Opportunity
Simpler Grants.gov #362951
Grant for Resources and Workforce Development at Regional Biocontainment Laboratories
Buyer
National Institutes of Health
Posted
June 24, 2026
Respond By
September 30, 2027
Identifier
362951
NAICS
541715, 611430
This opportunity from the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), supports the Regional Biocontainment Laboratories (RBLs) in the United States. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Purpose: - Provide resources, staff, and facility support for RBLs - Maintain and operate biosafety level 2 and 3 (BSL-2/3) laboratories for infectious disease research - Fund biocontainment-specific workforce training to ensure a capable BSL-3 workforce - Products/Services Requested: - Facility maintenance and operations support for RBLs - Biocontainment-specific workforce training - Notable Requirements: - Limited competition; only eligible higher education institutions (such as universities) may apply - Applications will undergo peer review for scientific merit - No specific OEMs, vendors, or product part numbers are mentioned, as this is a grant for operational and workforce support - Estimated Funding: - Total program funding is approximately $36,000,000 - Unique Aspects: - Focus on sustaining national BSL-3 laboratory capacity and workforce - Supports public health emergency response infrastructure
Description
The National Institute of Allergy and Infectious Diseases (NIAID) is seeking to provide critical resources, staff, and facilities support for the Regional Biocontainment Laboratories (RBLs), which offer biosafety level 2 and 3 biocontainment facilities for infectious disease research. This program aims to fund multi-year maintenance, operations, and biocontainment-specific training to maintain a capable BSL-3 workforce in the U.S. The opportunity is a limited competition inviting applications from eligible institutions, which will be peer-reviewed for merit. The funding instrument is a cooperative agreement with an estimated program funding of $36 million for fiscal year 2028.